The Q4 guidance for approximately $7 million in Adjusted EBITDA is the key near-term catalyst; if achieved, it would confirm the turnaround trajectory. Monitor the recovery in chemicals capacity utilization and the timing of $1.5 million in RIN sales and $2.3 million in derivative loss recoveries expected in Q4.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 10 $3.12entry
- T+1 · 6d ago −9.94%α −11.25% · $2.81
- T+4 · todayOpen
- T+5 · in 10h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FutureFuel reported Q3 2026 revenue of $104.7 million, up 361% YoY, driven by a surge in biofuel revenue to $87.8 million. However, the company posted a GAAP net loss of $8.4 million and an Adjusted EBITDA loss of $4.9 million, as chemicals segment volumes were disrupted by planned turnarounds and biofuel gross profit was negative due to elevated feedstock costs and derivative losses. Management guided for positive Adjusted EBITDA in Q4 and full-year 2026.
Key Financial Metrics
Key Facts
- Q3 2026 total revenue of $104.7 million, up 361.3% from $22.7 million in Q3 2025
- GAAP net loss of $8.4 million, or $0.19 per diluted share, versus a net loss of $9.2 million in Q3 2025
- Adjusted EBITDA loss of $4.9 million, compared to a loss of $5.3 million in the prior-year period
- Chemicals segment revenue of $16.9 million, up 8.6% YoY, but capacity utilization fell to 32% from 55% due to turnaround activity
- Biofuels segment revenue of $87.8 million, up from $7.1 million, but segment gross loss was $9.8 million due to elevated input costs and $8.7 million in net derivative losses
- Cash and equivalents fell to $21.3 million from $34.3 million at June 30, 2026; operating cash flow was negative $10.3 million in Q3
- Management expects Q4 2026 Adjusted EBITDA of approximately $7 million and positive Adjusted EBITDA for full-year 2026
- Customer-funded capital investments of $41 million committed over two years; full-year 2026 capex expected at $25.8 million
Financial Impact
Q3 revenue surged $82 million YoY to $104.7 million, but the company remained unprofitable with a net loss of $8.4 million and negative operating cash flow of $10.3 million. Cash balance declined by $13 million sequentially.
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Chemicals | $16.9M | +8.6% |
| Biofuels | $87.8M | +1134.1% |
Risk Factors
- Chemicals segment utilization dropped to 32% due to customer turnarounds; any further disruption could delay the Q4 recovery
- Biofuels segment remains unprofitable at the gross profit level due to elevated feedstock costs and derivative losses
- Cash burn continues; cash balance of $21.3 million with negative operating cash flow raises liquidity concerns if losses persist
- No consensus estimates were available; the stock's reaction may be driven by guidance rather than reported results
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-035901 |
| Document: ff20260827_8k.htm | 0001437749-26-035901 |
| Document: 0001437749-26-035901-index-headers.html | 0001437749-26-035901 |
| Document: 0001437749-26-035901-index.html | 0001437749-26-035901 |
| Document: 0001437749-26-035901.txt | 0001437749-26-035901 |
| 8-K Data (Synthetic) | 0001437749-26-035901 |
Track record
14 reports on FF
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today Insider Cluster Bullish 5/10 Entry $3.11 Now $2.90 −6.75% settles Nov 18
- Nov 13, 20263d ago Insider Cluster Neutral 4/10 Entry $2.98 Now $2.90 −2.68% settles Nov 17
- Nov 9, 20267d ago 8-K Bearish 5/10 Viewing Entry $3.12 to $2.81 Now $2.90 +7.05% ▲ +9.94% +11.25% vs SPY
- Oct 27, 202620d ago PRESS-RELEASE / 8-K Neutral 2/10 Entry $5.80 to $5.69 Now $2.90 −50.00% ▼ −1.90% −1.51% vs SPY
- Aug 10, 202614w ago 8-K Bullish 7/10 Entry $6.37 to $5.85 Now $2.90 −54.47% ▼ −8.16% −8.41% vs SPY
- Jul 28, 202615w ago 8-K Neutral 2/10 Entry $4.67 to $4.97 Now $2.90 −37.90% ▲ +6.42% +4.75% vs SPY
- Jun 30, 202619w ago 8-K Neutral 2/10 Entry $4.64 to $4.69 Now $2.90 −37.50% ▲ +1.08% +1.21% vs SPY
- Jun 26, 202620w ago 8-K Neutral 2/10 Entry $4.63 to $4.52 Now $2.90 −37.37% ▼ −2.38% −3.15% vs SPY
- May 11, 202627w ago 8-K Mixed 6/10 Entry $4.07 to $4.07 Now $2.90 −28.75% · 0.00% −0.54% vs SPY
- Apr 20, 202630w ago 8-K Neutral 2/10 Entry $4.23 to $4.25 Now $2.90 −31.44% ▲ +0.47% −0.55% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers